The formation of the atherosclerotic plaque that is characterized by the accumulation of abnormal amounts of cholesterol-loaded macrophages in the artery wall is mediated by both inflammatory events and alterations of lipid/lipoprotein metabolism. Reverse transport of cholesterol (RCT) opposes the formation and development of atherosclerotic plaque through high density lipoprotein (HDL) metabolism, promoting the removal of cholesterol from peripheral macrophages and its delivery back to the liver for excretion into the bile. Although an inverse association between HDL plasma levels and the risk of CVD has been demonstrated over the years, several studies have recently shown that the antiatherogenic functions of HDL appear to be mediated by ...